Chris Brigham, CFA

Senior Research Associate

6 Years at AB|14 Years of Experience

Chris Brigham is a Private Client Senior Research Associate at Bernstein. He joined Bernstein in 2018 as a member of the US Portfolio Strategy team. Prior to Bernstein, he worked in finance and strategy for EpiBone, a biotechnology startup. He has previously worked as a research analyst at Longview Asset Management and Tiresias Capital (Omni Partners) and as an event-driven analyst and trader at Bank of America Merrill Lynch. Chris earned his MBA from Columbia Business School, where he completed the Value Investing Program, and graduated Phi Beta Kappa with a BA in Economics from Claremont McKenna College. He completed the General Course at the London School of Economics and is a CFA charterholder. Location: New York

This website is authorized for use only by registered broker-dealers and is not authorized for use by the general public. The material contained herein is not for inspection by, distribution or quotation to, the general public. The sale of shares of AllianceBernstein funds may be restricted in certain jurisdictions. In particular, shares may not be offered or sold, directly or indirectly, in the United States or to US persons, as is more fully described in the prospectus with respect to each fund. Shares of AllianceBernstein funds are offered only pursuant to the fund's current prospectus together with the most recent financial statements. The information on this page is for information purposes only and should not be construed as an offer to sell, or solicitation to buy, or a recommendation for the securities of any AllianceBernstein fund.

AllianceBernstein provides its investment management services in Canada through its affiliates Sanford C. Bernstein & Co. LLC and AllianceBernstein Canada, Inc. Shares of the AllianceBernstein Luxembourg funds described herein are not registered in Canada for public sale to Canadian resident investors.

Published Work